[A case of recurrent breast cancer responding to combination therapy with mitoxantrone (MIT), 5'-deoxy-5-fluorouridine (5'-DFUR) and medroxyprogesterone acetate (MPA)].
Kobayashi J, Kubota K, Ishikawa H, Asaumi S, Iwanami K, Matsumoto H, Kawashima K, Yokoe T, Iino Y, Morishita Y. Gan To Kagaku Ryoho. 1994 Oct; 21(14):2513-6.